Table 3.

Comparison of the levels of EpCAM, TGM2, IL-33, CA125, and HE4 in pre- and post-operated endometrial cancer patients.

	Pre-operation	Post-operation	p
	Median (min-max)/Mean ± SD	Median (min-max)/Mean ± SD
EpCAM (pg/ml)	238.51 ± 53.82	254.81 ± 66.77	0.381
TGM2 (pg/ml)	534.85 (289.62–3,143.07)	0 (0–0)	<0.001
IL-33 (pg/ml)	6.69 (0.30–65.08)	6.04 (0.59–84.00)	0.937
CA125 (ng/ml)	23.07 ± 13.05	19.07 ± 10.06	0.100
HE4 (pmol/ml)	58.59 (39.94–291.30)	59.79 (35.00–257.60)	0.158

The statistical analysis of EpCAM and CA125 are tested by paired-samples t-test. TGM2, IL-33, TG, and HE4 are tested by Wilcoxon signed-rank. p < 0.05 is considered as statistically significant.